Literature DB >> 1610199

Filtration sizes of human immunodeficiency virus type 1 and surrogate viruses used to test barrier materials.

C D Lytle1, S C Tondreau, W Truscott, A P Budacz, R K Kuester, L Venegas, R E Schmukler, W H Cyr.   

Abstract

Filters with well-defined holes were used to determine the effective diameters in buffer of human immunodeficiency virus type 1, herpes simplex virus type 1, and four bacteriophages (phi X174, T7, PRD1, and phi 6), which may serve as surrogate viruses for testing barrier materials. Bacteriophages phi 6 and PRD1 most closely model human immunodeficiency virus type 1 in filtration size.

Entities:  

Mesh：

Year:  1992        PMID： 1610199      PMCID： PMC195319          DOI： 10.1128/aem.58.2.747-749.1992

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  22 in total

1.  Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

Authors:  J S McDougal; S P Cort; M S Kennedy; C D Cabridilla; P M Feorino; D P Francis; D Hicks; V S Kalyanaraman; L S Martin
Journal:  J Immunol Methods       Date:  1985-01-21       Impact factor: 2.303

2.  Condoms prevent transmission of AIDS-associated retrovirus.

Authors:  M Conant; D Hardy; J Sernatinger; D Spicer; J A Levy
Journal:  JAMA       Date:  1986-04-04       Impact factor: 56.272

3.  Differential inactivation of surrogate viruses with merocyanine 540.

Authors:  C D Lytle; A P Budacz; E Keville; S A Miller; K N Prodouz
Journal:  Photochem Photobiol       Date:  1991-09       Impact factor: 3.421

Review 4.  Use of ultrafiltration for animal virus grouping.

Authors:  G D Hsiung
Journal:  Bacteriol Rev       Date:  1965-12

5.  Determining the size of non-A, non-B hepatitis virus by filtration.

Authors:  L F He; D Alling; T Popkin; M Shapiro; H J Alter; R H Purcell
Journal:  J Infect Dis       Date:  1987-10       Impact factor: 5.226

6.  Efficacy of commercial condoms in the prevention of hepatitis B virus infection.

Authors:  G Y Minuk; C E Bohme; T J Bowen; D I Hoar; S Cassol; M J Gill; H C Clarke
Journal:  Gastroenterology       Date:  1987-10       Impact factor: 22.682

7.  Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus.

Authors:  M A Gonda; F Wong-Staal; R C Gallo; J E Clements; O Narayan; R V Gilden
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

8.  Condoms as physical and chemical barriers against human immunodeficiency virus.

Authors:  C A Rietmeijer; J W Krebs; P M Feorino; F N Judson
Journal:  JAMA       Date:  1988-03-25       Impact factor: 56.272

9.  Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources.

Authors:  S Z Salahuddin; P D Markham; M Popovic; M G Sarngadharan; S Orndorff; A Fladagar; A Patel; J Gold; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

10.  The latex condom, an efficient barrier against sexual transmission of AIDS-related viruses.

Authors:  P Van de Perre; D Jacobs; S Sprecher-Goldberger
Journal:  AIDS       Date:  1987-05       Impact factor: 4.177
View more
  3 in total

1.  Virus passage through track-etch membranes modified by salinity and a nonionic surfactant.

Authors:  C D Lytle; L B Routson; N B Jain; M R Myers; B L Green
Journal:  Appl Environ Microbiol       Date:  1999-06       Impact factor: 4.792

2.  Minimized virus binding for tests of barrier materials.

Authors:  C D Lytle; L B Routson
Journal:  Appl Environ Microbiol       Date:  1995-02       Impact factor: 4.792

Review 3.  Bacteriophage Capsid Modification by Genetic and Chemical Methods.

Authors:  Caitlin M Carmody; Julie M Goddard; Sam R Nugen
Journal:  Bioconjug Chem       Date:  2021-03-04       Impact factor: 4.774
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.